# Safety and Efficacy of Heterologous FMT by SQIMC-md Capsule in Mild-moderate Ulcerative Colitis Patients

> **NCT04034758** · NA · UNKNOWN · sponsor: **Tongji Hospital** · enrollment: 99 (estimated)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **PROCEDURE:** Standardized Quantitative multi-donor Intestinal Microbiota Capsule (SQIMC-md)
- **PROCEDURE:** placebo capsule

## Key facts

- **NCT ID:** NCT04034758
- **Lead sponsor:** Tongji Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-08-30
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 99 (ESTIMATED)
- **Last updated:** 2019-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04034758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04034758, "Safety and Efficacy of Heterologous FMT by SQIMC-md Capsule in Mild-moderate Ulcerative Colitis Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04034758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*